Latest News

Vice Chancellor for Research, Graduate Student Develop COVID-19 Contact-Tracing Tool

May 22, 2020

Computer scientists at the University of California, Davis, have developed a web-based contact-tracing application. The app, We-Care, allows users to check in at specific locations and notifies them if someone reporting themselves as positive for COVID-19 checks in at the same location within a certain  time window.

Troubling COVID-19 syndrome identified in children

May 19, 2020
UC Davis Children's Hospital researches illness in kids similar to Kawasaki disease

(SACRAMENTO) — If there’s some good news in the novel coronavirus pandemic, it’s that children have been far less susceptible to it. When children have become infected, the vast majority have mild symptoms. Worldwide, children younger than 10 years make up only 1% of COVID 19 cases. However, a newly identified and severe inflammatory syndrome – similar to Kawasaki disease  ̶  has been linked to the coronavirus causing COVID-19 in about 200 children in the United States and Europe.

Panel Cuts Through COVID-19 Confusion

May 19, 2020

UC Davis leaders and researchers gathered virtually May 14 to answer the public’s questions about COVID-19, ranging from the safety of homemade masks to whether children or pets could transmit the virus.

Distinguished Professor Walter Leal brought the panel together for his second COVID-19 Public Awareness Symposium. It featured straight talk from experts about many areas that have been shrouded in confusion and conflicting information.

UC Davis LIVE: Treating COVID-19

May 19, 2020

In the second edition of UC Davis LIVE: COVID-19, two UC Davis clinicians will talk about and take questions on the new treatments for COVID-19 being tested at UC Davis Health and other hospitals, including the experimental antiviral drug remdesivir — used to treat UC Davis’ first patient of the pandemic in March — and using plasma from people who have recovered from the novel coronavirus to treat patients.

National Science Foundation Grant to Help UC Davis Researchers Track Evolution of Novel Coronavirus

May 13, 2020

As the disease COVID-19 spreads across the planet, scientists continue to combat the novel coronavirus (SARS-Cov-2) on all fronts. But viruses are fickle, mutating to ensure their survival as they hop hosts. Genomic mutations and natural selection could reduce the effectiveness of a potential vaccine for the novel coronavirus, and different sequence variations and strains of the virus are continuously being reported in databases like GISAID.

Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?

May 12, 2020
UC Davis scientists provide senicapoc for clinical trial in Denmark

(SACRAMENTO) — Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.

UC Davis Health researchers provided one of those repurposed drugs, senicapoc, to launch a clinical trial at Aarhus University in Denmark. The study will assess whether the drug can mitigate lung damage in patients with COVID-19.

COVID-19 ‘Live’ Series Debuts May 7

May 05, 2020

‘Deans Discuss’ Podcast Launches Later in Month

By Andy Fell on May 5, 2020 in University  

UC Davis is launching two new series that take a deep dive into how our researchers are meeting the challenge of COVID-19. They will explore how UC Davis scientists, clinicians, engineers and others, often working across disciplines, are turning their knowledge to tackle COVID-19, from its origin to our communities and hospitals.

As Americans Shelter in Place, Traffic, Emissions and Fuel-Tax Revenues Decline Dramatically

May 01, 2020
COVID-19 Mitigation Efforts Could Put U.S. on Track to Meet Paris Climate Accord Goals

Americans drove drastically less, saved millions of metric tons of greenhouse gases, and, in some states, lost millions in fuel-tax revenue since COVID-19 mitigation efforts took effect in early March. That is according to the latest special report from the Road Ecology Center at the University of California, Davis.

UC Davis Health conducts first plasma transfusions for COVID-19

April 29, 2020
Call for blood donations from those who have tested positive and been symptom-free for at least 28 days.

(SACRAMENTO) — Two UC Davis Health patients with COVID-19 have received plasma transfusions from a blood donor who recovered from the virus in an effort to boost the sick patients’ abilities to neutralize the virus and its devastating effects.

COVID-19 Limitations Unique Opportunity for Researchers to Decrease Digital Divide

April 29, 2020
Researchers Need to Develop New Ways to Reach Rural Participants

The COVID-19 shelter-in-place orders and other limitations could offer researchers the chance to use technology to decrease the digital divide and disparities in academic research, suggests a University of California, Davis, professor in a new commentary.

UC Davis Engineers, Clinician Develop Low-Cost, Portable Ventilator

April 29, 2020

Engineers at the University of California, Davis, are working with clinicians to create a simple, inexpensive ventilator. They have developed a prototype and plan to make plans freely available online. Versions could be in clinical use in about six months.

“This is a critical device to have. It provides the vital functions of a ventilator while being completely portable,” said Andrew Li, assistant professor in the Department of Surgery at UC Davis Health.